Cleerly

???? Recently, we’ve become aware of fake job postings or job offers using the?Cleerly?name and logo without our knowledge. ???? Recruiting fraud occurs when individuals impersonate recruiters, hiring managers, or employees to deceive candidates into sharing personal information (resume, social security number, bank account information, driver’s license, passport, etc.). Recruiting at Cleerly: *All open jobs are posted on our official LinkedIn page and our Careers page:?https://lnkd.in/eixch7SK?(if you see a Cleerly job posted on another job board, confirm that the job is also posted on our website and apply directly from our Careers Page). *All communication from Cleerly will come from our corporate email domain (@cleerlyhealth.com). We do not use other website domain names for emails. *We conduct all interviews at Cleerly via phone call or Zoom. We never text or use chat services to conduct interviews. *When you move to the final interview stages at Cleerly, you will be contacted by our Senior Talent Partner from our corporate email domain (@cleerlyhealth.com) and receive an offer letter via DropBox Sign. *We will never ask for bank account information, social security number, or any other personal information during the interview process. We will never ask for you to deposit checks on behalf of the company as part of a job offer.

?? Hard Work Pays Off! ?? Expanded Medicare coverage for Cleerly’s coronary plaque analysis is officially in effect for areas covered by Medicare Administrative Contractors CGS, NGS, WPS, and Palmetto! Coverage for Noridian will begin on December 8th. We’re proud to have led this initiative with our coverage request in February 2023. This marks a significant step toward providing non-invasive coronary artery disease assessments to millions of Medicare recipients. ?? Applicable Coding Information: CPT? Codes 0623T, 0624T, 0625T, 0626T Learn more about how this change impacts care: https://lnkd.in/g38dHVpH #YesCCT #AIQCT #CardiacCare #CardiacImaging

??? Countdown to RSNA 2024! ??? Join Cleerly at the world's largest radiology conference from December 1 - 4 at Chicago's McCormick Place! Visit us at Booth #3905 to explore our standard of precision heart care and learn how Cleerly can aid workflow efficiency with CCTA analysis, rapid turnaround times, and seamless PACS integrations. Whether you're a healthcare provider focused on enhancing patient care or exploring the latest innovations in cardiac imaging, we're eager to connect and share how Cleerly is transforming the future of cardiac care. Discover how Cleerly provides conclusive and decisive diagnostic reports. Book your RSNA meeting today! ?? https://lnkd.in/gg7cD9SQ #RSNA2024 #Radiology #YesCCT #CCTA #HeartDisease #CardiacImaging #RSNA

Yesterday, over 100 investigators gathered in Chicago to share experiences in the TRANSFORM randomized clinical trial! ???? Patient enrollment for the trial began in March, and after the AHA meeting, investigators from 30 sites and trial leadership came together to share early insights. There was clear excitement about the progress made and how truly transformative this trial could be for heart attack prevention. As the trial sponsor, we’re grateful to work with such strong leaders and teams driving this mission forward. Deepak L. Bhatt, MD, MPH, MBA, Dr. David Maron, CPC Learn more about the TRANSFORM trial: ?? https://lnkd.in/gdzCF5HT #YesCCT #ClinicalTrial #HeartAttackPrevention #PreventiveCare #CardiacCare

?? That's a wrap on AHA 2024! ?? A heartfelt thank you to the American Heart Association for fostering innovation and creating a space for industry leaders to gather and share groundbreaking scientific and clinical findings. The Cleerly team was blown away by the overwhelming interest in our AI-powered solutions for aiding the diagnosis and management of coronary artery disease. It was great to connect with those who share our vision for a future where cardiac care is precise, proactive, and personalized. Together, we can create a world without heart attacks! ???? A special highlight: the presentation of four impactful abstracts! You can explore these cutting-edge findings here: ??New Discoveries in Microvascular Disease and Coronary Artery Disease: Sex and Age Differences ?? https://lnkd.in/gUwBrbqB ??New Concepts Regarding Vulnerable Plaque ?? https://lnkd.in/gVu56FKT ??Sex Differences in CVD 2 ?? https://lnkd.in/gbjqyeuz ??Coronary and Non-coronary Applications of Coronary CT and Photon Imaging ?? https://lnkd.in/gAjJzDPu Couldn't make it to AHA 2024? Let's keep the momentum going—book a 1:1 demo to see how Cleerly is redefining cardiac care and discover what's next for your practice. https://lnkd.in/gG6x7rBr #AHA2024 #YesCCT #CardiacImagining #ClinicalResearch #HeartDisease #PreventiveCare

?? Elevate your approach to cardiac care! Join us on?December 16th at 10 AM ET?for The Next Step in Predicting Coronary Events: How Advanced Plaque Analysis Supports Prognosis. Our featured speaker,?Sarah B?r, MD, PhD, will share how?Cleerly's AI-powered coronary CTA plaque analysis?is transforming coronary artery disease (CAD) risk prediction, going beyond traditional tests. Plus, get your questions answered live by Cleerly Founder & CEO,?James K. Min, MD, and CMO,?James P Earls, MD, FSCCT. Don't miss the chance to learn about the future of CAD prevention—register now! https://lnkd.in/g8ztH6ar #YesCCT #HeartHealth #Cardiology #AIinHealthcare #PreventiveCare

We're live at the American Heart Association Scientific Sessions! ???? It’s been an exciting start here at AHA 2024! Dr. James Min, MD, our CEO & Founder, shared his journey from cardiology to healthcare innovation, joining other thought leaders in the field. Key discoveries from the ISCHEMIA Trial and the global ICONIC study were also unveiled. The response to our AI-powered CCTA analysis has been incredible, and we're excited to see so much interest in how Cleerly’s solutions help guide personalized prognosis, diagnosis, and treatment of coronary artery disease. ?? Stop by Booth 5 in the Health Innovation Pavilion! We’d love to connect, discuss key findings from the ISCHEMIA and ICONIC studies, or provide a live demo. Check out our full schedule.?? https://lnkd.in/gFzef6sZ #AHA2024 #YesCCT #DigitalHealth #HealthTech #Cardiology #HeartHealth

Did you know heart disease is the leading cause of death for active-duty firefighters? Firefighters face higher risks from physical strain, stress, and the job's demands. According to the U.S. Fire Administration, 44% of firefighter fatalities are due to sudden cardiac events, often tied to heart disease. ?? At Cleerly, we're incredibly grateful to support our local heroes like John Curtis through our partnership with South Metro Fire Rescue, where we'll be performing screenings for nearly 700 first responders over the next two years. Stay tuned for more stories from the front lines—because it's our turn to look after them! ???? #YesCCT #HeartDisease #PreventiveCare #FirstResponders #CardiacImaging

AI is changing the game in ischemia detection. ?? Watch our CMO, Dr. James P Earls MD, FSCCT, discuss how Cleerly ISCHEMIA uses machine learning and concise reporting to aid physicians in personalizing patient treatment. Don’t miss this insightful interview on the Cardiac Wire Show! #YesCCT #DigitalHealth #Cardiology #PreventiveCare

?? Did someone say research? Cleerly is bringing groundbreaking insights on coronary artery disease (CAD) to the American Heart Association Scientific Sessions, November 16-18 in Chicago!?? We're thrilled to present significant findings on AI-Quantitative Coronary CT (AI-QCT) imaging, including insights into coronary artery plaque characteristics and important sex and age-related differences. Join us at Booth 5 in the Health Innovation Pavilion to explore how our AI-enabled CCTA solutions can help guide personalized evaluations and treatments for CAD. ?? Don't miss a beat—check out the full story! https://lnkd.in/gHYsq5qa #AHA2024 #AIinHealthCare #AIQCT #YesCCT